Journal: Applied Health Economics and Health Policy

Article Title: Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

doi: 10.1007/s40258-015-0153-x

Figure Lengend Snippet: Model used for evaluating the efficiency of Thrombo inCode ® (TiC), a clinical–genetic function for estimating the risk of venous thromboembolism (VTE) in patients with potential thrombophilia, versus the standard method used to date (factor V Leiden and prothrombin G20210A) . Plus indicates that the standard method sub-tree has the same structure as the TiC sub-tree, but it has been hidden to simplify the figure. DVT Deep vein thrombosis, FN false negative, FP false positive, PE pulmonary embolism, TN true negative, TP true positive

Article Snippet: DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism Additionally, TiC was the dominant treatment, irrespective of the timeline chosen (between 1 and 35 years) in patients from both populations.

Techniques:

Journal: Applied Health Economics and Health Policy

Article Title: Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

doi: 10.1007/s40258-015-0153-x

Figure Lengend Snippet: Deterministic sensitivity analysis: tornado diagrams. a S. PAU population. b MARTHA population. K indicates thousands, e.g. 240 K is EUR 240,000. DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism

Article Snippet: DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism Additionally, TiC was the dominant treatment, irrespective of the timeline chosen (between 1 and 35 years) in patients from both populations.

Techniques:

Journal: Applied Health Economics and Health Policy

Article Title: Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

doi: 10.1007/s40258-015-0153-x

Figure Lengend Snippet: Monte Carlo probabilistic analysis. a S. PAU population. b MARTHA population. 1,000 simulations were performed in a hypothetical cohort of 10,000 patients. The cost per patient is lower with Thrombo inCode ® than with the standard method in 100 % of the simulations. QALY quality-adjusted life-year

Article Snippet: DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism Additionally, TiC was the dominant treatment, irrespective of the timeline chosen (between 1 and 35 years) in patients from both populations.

Techniques:

Journal: Applied Health Economics and Health Policy

Article Title: Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

doi: 10.1007/s40258-015-0153-x

Figure Lengend Snippet:

Article Snippet: DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism Additionally, TiC was the dominant treatment, irrespective of the timeline chosen (between 1 and 35 years) in patients from both populations.

Techniques:

Journal: Applied Health Economics and Health Policy

Article Title: Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism

doi: 10.1007/s40258-015-0153-x

Figure Lengend Snippet: Venous thromboembolism (VTE) predictive capacity in identifying thrombophilia with Thrombo inCode ® (TiC) and with the standard method (SM), assessed in two case–control studies [ 7 ]

Article Snippet: DVT Deep vein thrombosis, PE pulmonary embolism, Prob probability, QALY quality-adjusted life-year, TiC Thrombo inCode ® , TN true negative, TP true positive, VTE venous thromboembolism Additionally, TiC was the dominant treatment, irrespective of the timeline chosen (between 1 and 35 years) in patients from both populations.

Techniques: